LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
4.970
-0.700 (-12.35%)
At close: Oct 22, 2026, 4:00 PM EDT
5.06
+0.09 (1.81%)
After-hours: Oct 22, 2026, 7:47 PM EDT
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $46.83 million as of October 22, 2026. It is the 30,594th most valuable company in the world and the 4,660th biggest in the United States. Its market cap has increased by 178.71% in one year.
Market Cap
46.83M
Enterprise Value
-3.66M
1-Year Change
178.71%
Global Rank
Country Rank
#4,660 United States
Category
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $46.83M, a decrease of -91.12%. That is a compound annual growth rate of -32.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 46.83M | 56.84% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 55.51M |
| Boundless Bio | 55.50M |
| Xilio Therapeutics | 55.47M |
| Alps Group | 54.91M |
| Pliant Therapeutics | 54.85M |
| MiNK Therapeutics | 54.19M |
| iBio, Inc. | 54.02M |
| Rein Therapeutics | 53.90M |